Comparison of two alternative combinations of nucleosides in HIV-1 infected patients with viral suppression on 3TC [lamivudine]. Randomized, multicentre open trial.
Phase of Trial: Phase III
Latest Information Update: 07 Sep 2012
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Lamivudine/abacavir (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms BICOMBO
- 28 Feb 2012 Results published in Antiviral Therapy.
- 10 May 2011 Additional lead trial centre identified as reported by European Clinical Trials Database.
- 10 May 2011 New source identified and integrated (European Clinical Trials Database; EudraCT2005-000005-65).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History